TGFB1 and neoplasm: β-estradiol (E2) and ESR2 (ERβ) were the strongest activated regulators identified, reinforcing ERβ’s direct role in transcriptional control of key tumor suppressive genes involved in TGFβ signaling, ECM remodeling, metabolic shifts, and cytokine modulation.